Coronavirus disease 2019 (COVID-19) has been confirmed in 21,294,845 people worldwide as of 16th August 2020, carrying a mortality of nearly 4%, compared with a mortality rate of less than 1% from influenza [ 1 ]. Although this mortality rate maybe …
Autoren:
H. Burke, A. Freeman, D. C. Cellura, B. L. Stuart, N. J. Brendish, S. Poole, F. Borca, H. T. T. Phan, N. Sheard, S. Williams, C. M. Spalluto, K. J. Staples, T. W. Clark, T. M. A. Wilkinson, on behalf of the REACT COVID investigators
Due to the high pathogenicity and mortality, the COVID-19 disaster caused global panic and anxiety. At present, diagnosis and treatment are of great concern. As time progresses, however, the sequelae caused by many other organ system complications …
Autoren:
Guo Heng Mo, Zi Xuan Wang, Xiao Si Chen, Qunguang Jiang
The novel coronavirus disease (COVID-19) has put an additional strain on Afghanistan’s weak healthcare system. Prior to the pandemic, the government and its allies had already problems in providing high quality health services for the people in …
Autoren:
Don Eliseo Lucero-Prisno III, Mohammad Yasir Essar, Attaullah Ahmadi, Xu Lin, Yusuff Adebayo Adebisi
The novel coronavirus diseases 2019(COVID-19) first reported in Wuhan, Hubei province, China [ 1 , 2 ]. It then spread widely in China and other nations around the world [ 3 , 4 ]. With the COVID-19 global pandemic, more and more cases of death …
Autoren:
Tao Yao, Yan Gao, Qin Cui, Bo Peng, Yan Chen, Jiansheng Li, Chao Huang, Chunping He, Jie Pu, Jiajun Wei, Yanqiang Zhan, Jie Yan, Jinghua Tian, Zhaohui Zhang, Zhichao Liu
During the outbreak of coronavirus 2019 (COVID-19) [ 1 – 3 ], a small proportion of confirmed COVID-19 patients fail to produce IgM or IgG antibodies against SARS-CoV-2 even 40 days or longer periods of time after onset of their initial symptoms.
Autoren:
Jian Wang, Chong Chen, Qilin Li, Pengcheng Cai, Zheng Wang, Lin Wang
COVID-19, the pandemic caused by the severe acute respiratory syndrome (SARS) coronavirus-2 (SARS-CoV-2), is challenging healthcare systems worldwide. In some countries, the number of serious cases has exceeded the resources available and the …
Autoren:
Peter Hilbert-Carius, Jörg Braun, Fikri Abu-Zidan, Jörn Adler, Jürgen Knapp, Didier Dandrifosse, Désirée Braun, Urs Pietsch, Patrick Adamczuk, Leif Rognås, Roland Albrecht
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in 2019, spread to most of the countries around the world, and the corona virus disease 2019 (COVID-19) has progressed into a global pandemic. Globally, as of …
Autoren:
Jie Li, Junwei Wang, Yi Yang, Peishan Cai, Jingchao Cao, Xuefeng Cai, Yu Zhang
In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan City, China and rapidly developed into a pandemic that poses a serious threat to health care systems worldwide [ 1 – 3 ]. It soon became apparent …
Autoren:
Stefanie Kampmeier, Hauke Tönnies, Carlos L. Correa-Martinez, Alexander Mellmann, Vera Schwierzeck
Optimal management of thrombotic complications that are recognised as a common feature of coronavirus disease 2019 (COVID-19) remains a major clinical challenge in intensive care units (ICUs) [ 1 – 3 ]. Proposed underlying mechanisms include an …
Autoren:
Akshay Shah, Killian Donovan, Anna McHugh, Manish Pandey, Louise Aaron, Charlotte A. Bradbury, Simon J. Stanworth, Raza Alikhan, Stephen Von Kier, Keith Maher, Nicola Curry, Susan Shapiro, Matthew J. Rowland, Matt Thomas, Richard Mason, Matthew Holland, Tom Holmes, Michael Ware, Stefan Gurney, Stuart R. McKechnie
The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete …
Stefan Roehrig, Ali Ait Hssain, Nabil Al Hamid Shallik, Ingi Mohamed A. Elsaid, Salma Faisal Mustafa, Osama A. M. Smain, Ashraf Abdulla Molokhia, Marcus D. Lance
The outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health. The genetic traits as well as evolutionary processes in this novel …
The global pandemic of COVID-19, caused by the highly infectious and transmissible coronavirus, SARS-CoV-2, has become a leading cause of death in older adults [ 1 ]. While adults can develop life-threatening complications such as pneumonia, acute …
Autoren:
Rosiane Lima, Elizabeth F. Gootkind, Denis De la Flor, Laura J. Yockey, Evan A. Bordt, Paolo D’Avino, Shen Ning, Katerina Heath, Katherine Harding, Jaclyn Zois, Grace Park, Margot Hardcastle, Kathleen A. Grinke, Sheila Grimmel, Susan P. Davidson, Pamela J. Forde, Kathryn E. Hall, Anne M. Neilan, Juan D. Matute, Paul H. Lerou, Alessio Fasano, Jessica E. Shui, Andrea G. Edlow, Lael M. Yonker
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified first on January 10 in Wuhan, China. This virus triggers the COVID-19 pandemic, which was classified by the WHO on January 30, 2020, as a health emergency of international …
Autoren:
Claudia Traunmüller, Rene Stefitz, Kerstin Gaisbachgrabner, Andreas Schwerdtfeger
An amendment to this paper has been published and can be accessed via the original article.
Autoren:
Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, Alessandro Cuomo, Robin Emsley, Andrea Fagiolini, Giuseppe Imperadore, Taishiro Kishimoto, Giulia Michencigh, Michela Nosé, Marianna Purgato, Serdar Dursun, Brendon Stubbs, David Taylor, Graham Thornicroft, Philip B. Ward, Christoph Hiemke, Christoph U. Correll, Corrado Barbui
The COVID-19 pandemic is creating global disruption, causing markets to plummet and generating many questions in every area of life. Since it affects health in multiple ways, including sexual and reproductive health, publishing in all these areas …
Autoren:
Welma Lubbe, Elina Botha, Hannakaisa Niela-Vilen, Penny Reimers
Since the first case of novel coronavirus disease 2019 (COVID-19) was reported in Tokyo on January 24, 2020 [ 1 ], the number of cases has continued to rise [ 2 ]. “A state of emergency” was declared from April 7 to May 25, 2020. The total number …